{
  "elems":[
    {
      "type":"t",
      "desc":"Empiric antibiotic regimens. Normal renal function"
    },
    {
      "type":"es",
      "desc":"One of the following antibiotics"
    },
    {
      "type":"e",
      "desc":"Amoxicillin/clavulanate 1.2-2.2 g 8-hourly"
    },
    {
      "type":"e",
      "desc":"Ceftriaxone 2 g 24-hourly + Metronidazole 500 mg 6-hourly"
    },
    {
      "type":"e",
      "desc":"Cefotaxime 2g 8-hourly + Metronidazole 500 mg 6-hourly"
    },
    {
      "type":"e",
      "desc":"OR"
    },
    {
      "type":"es",
      "desc":"In patients with beta-lactam allergy"
    },
    {
      "type":"t",
      "desc":"A fluoroquinolone-based regimen"
    },
    {
      "type":"e",
      "desc":"Ciprofloxacin 400 mg 8/12-hourly + Metronidazole 500 mg 6- hourly"
    },
    {
      "type":"e",
      "desc":"OR"
    },
    {
      "type":"t",
      "desc":"An aminoglycoside regimen"
    },
    {
      "type":"e",
      "desc":"Amikacin 15â€“20 mg/kg 24-hourly+ Metronidazole 500 mg 6- hourly"
    },
    {
      "type":"t",
      "desc":"OR"
    },
    {
      "type":"es",
      "desc":"In patients at high risk for infection with community-acquired ESBL-producing Enterobacteriaceae"
    },
    {
      "type":"es",
      "desc":"One of the following antibiotics"
    },
    {
      "type":"e",
      "desc":"Tigecycline* 100 mg LD, then 50 mg 12-hourly (Carbapenem sparing strategy)"
    },
    {
      "type":"e",
      "desc":"Ertapenem 1 g 24-hourly"
    },
    {
      "type":"e",
      "desc":"Meropenem 1 g 8-hourly (only in patients with septic shock)"
    },
    {
      "type":"e",
      "desc":"Doripenem 500 mg 8-hourly (only in patients with septic shock)"
    },
    {
      "type":"e",
      "desc":"Imipenem/Cilastatin 500 mg 6-hourly (only in patients with septic shock)"
    }
  ]
}
